Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Two-years Follow-up of Melanoma Patients Treated by Nivolumab During the French ATU Program

NCT03325257 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT03325257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03325257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Two-years Follow-up of Melanoma Patients Treated by Nivolumab During the French ATU Program
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Completed
Start date
March 9, 2017
Completion date
March 1, 2019
Enrollment
350 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma